202 related articles for article (PubMed ID: 30572133)
1. Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine.
Goules AV; Tzioufas AG
Autoimmun Rev; 2019 Feb; 18(2):137-143. PubMed ID: 30572133
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
3. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
[TBL] [Abstract][Full Text] [Related]
4. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
5. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
[TBL] [Abstract][Full Text] [Related]
6. Secondary tumours in Sjögren's syndrome.
Kovács L; Szodoray P; Kiss E
Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
Nezos A; Mavragani CP
J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
[TBL] [Abstract][Full Text] [Related]
9. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
11. New frontiers in precision medicine for Sjogren's syndrome.
Chatzis L; Vlachoyiannopoulos PG; Tzioufas AG; Goules AV
Expert Rev Clin Immunol; 2021 Feb; 17(2):127-141. PubMed ID: 33478279
[No Abstract] [Full Text] [Related]
12. Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome.
Navarro-Mendoza EP; Aguirre-Valencia D; Posso-Osorio I; Correa-Forero SV; Torres-Cutiva DF; Loaiza D; Tobón GJ
Autoimmun Rev; 2018 Jul; 17(7):709-714. PubMed ID: 29729452
[TBL] [Abstract][Full Text] [Related]
13. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
15. World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome-A systematic review.
Delli K; Villa A; Farah CS; Celentano A; Ojeda D; Peterson DE; Jensen SB; Glurich I; Vissink A
Oral Dis; 2019 Jun; 25 Suppl 1():49-63. PubMed ID: 30663837
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferation in autoimmunity and Sjögren's syndrome.
Voulgarelis M; Moutsopoulos HM
Curr Rheumatol Rep; 2003 Aug; 5(4):317-23. PubMed ID: 14531960
[TBL] [Abstract][Full Text] [Related]
17. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
Mariette X
Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
19. High frequency of light chain restriction in labial gland biopsies of Sjögren's syndrome detected by in situ hybridization.
Jordan RC; Pringle JH; Speight PM
J Pathol; 1995 Sep; 177(1):35-40. PubMed ID: 7472777
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L
Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
